Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation

from Value in Health at http://bit.ly/2vu9f3H on August 2, 2017 at 11:25PM


Publication date:
Source:Value in Health
Author(s): Piyameth Dilokthornsakul, Mausam Patidar, Jonathan D. Campbell

Advertisements